Arya Consulting Partners announced that Founder and President Nida Khan was recently featured in an interview for the PharmaMarketing Summit 2026, an invitation‑only event produced by Marcus Evans and attended by senior pharmaceutical marketing leaders.
In the interview, Nida shared perspectives on the evolving complexity of biopharmaceutical launches, emphasizing the need for earlier, more integrated planning across medical, commercial, access, and data functions. She highlighted how changes in data availability, analytics, and real‑world evidence are reshaping launch strategy, particularly for specialty and rare disease products.
Nida also discussed the growing role of advanced analytics and artificial intelligence in enabling organizations to better identify patients, align stakeholders, and adapt strategy as market conditions evolve. According to her, successful launches increasingly depend on treating commercialization as a continuous, dynamic process rather than a single milestone.
The PharmaMarketing Summit 2026 convenes pharmaceutical marketing executives to address emerging trends, challenges, and best practices shaping the future of biopharmaceutical commercialization.
Get expert analysis, industry trends, and exclusive updates delivered straight to your inbox. Stay ahead of the curve with valuable insights that drive success.
